Home›Stock Screener›Indegene

Indegene Share Price Today | Stock Price & Indegene Share Screener

INDGN Healthcare Services
Live Share Price NSE
₹654.95
▲ 6.20 (0.96%)
2026-11-18 00:00:00
Live Share Price BSE
₹653.50
▲ 4.55 (0.70%)
2026-11-18 00:00:00

As of November 18, 2026, the live Indegene share price (NSE: INDGN) is ₹654.95 on NSE and ₹653.50 on BSE, up 0.96% from the previous close, with shares trading between ₹646.05 and ₹662.55 in today's trading session, and a 52-week range of ₹423.50–₹666.20. Track Indegene market worth to gauge the company's total market size. Use the Indegene stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Indegene opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹1,137 and net income of ₹112, with EBITDA of ₹201, an operating margin of 17.0% and a profit margin of 9.9%.

Indegene Market Cap ₹15,632.72 Cr.
INDGN P/E Ratio (TTM) 38.80
Indegene P/B Ratio 4.75
EPS (TTM) ₹16.72
Dividend Yield 0.34%
Debt to Equity 0.04
INDGN 52 Week High ₹666.20
Indegene 52 Week Low ₹423.50
Operating Margin 17.00%
Profit Margin 9.85%
INDGN Revenue (TTM) ₹1,137.00
EBITDA ₹201.00
Net Income ₹112.00
Total Assets ₹4,620.00
Total Equity ₹3,139.00

Indegene Share Price Chart

Track the current stock price of Indegene with an interactive chart. Analyse INDGN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Indegene stock quote in one place.

The quote of ₹654.95 sits between the 52-week low of ₹423.50 and the 52-week high of ₹666.20, and the latest session moved 0.96% from the previous close.

Indegene Company Profile - Fundamental Screener

Screen Indegene company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INDGN shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, with Manish Gupta listed as chairperson or CEO, and it trades under ISIN INE065X01017.

Business Overview

Indegene Limited is a global provider of digital-led commercialization services for the life sciences industry. The company offers solutions in analytics, technology, and commercial, medical, regulatory, and safety services to biopharmaceutical, emerging biotech, and medical devices companies. Indegene operates through four main segments: Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical...more

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

Chairperson/CEO Manish Gupta
ISIN INE065X01017

Indegene Balance Sheet Screener

Screen INDGN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹4,620, up from ₹3,326 in 2025.

Latest statistics put total assets at ₹4,620 and shareholder funds at ₹3,139, with a leverage ratio of 0.04.

Item 2026 2025 2024 2023 2022 2021 2020 2019

Assets

Total Assets 4,620 3,326 2,546 2,204 1,354 596 600 329
Current Assets 0 0 0 0 0 0 0 0
Fixed Assets 1,812 678 646 664 138 86 119 104

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 395 146 506 651 149 64 369 18
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 3,139 2,616 1,429 1,064 764 333 -16 152
Share Capital 48 48 44 44 0 0 0 79
Reserves & Surplus 3,090 2,567 1,385 1,020 764 324 -105 73

Indegene Income Statement Screener - Profit & Revenue Analysis

Screen Indegene income statement and profit fundamentals. Analyze INDGN quarterly results. Indegene reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹1,137 and net profit was ₹112, equal to earnings per unit of ₹4.67, at an operating margin of 17%.

In that period expenses were ₹937, interest cost ₹7 and tax ₹35. The next period listed, 2026-Jun, shows revenue of ₹1,092 and net profit of ₹116.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar

Revenue and Expenses

Revenue 1,137 1,092 1,014 962 824 783 781 758 708 699 699 687 647 636 645
Expenses 937 889 860 783 664 606 608 589 561 548 534 525 515 511 535

Operating Costs and Margins

EBITDA 201 203 154 179 160 177 173 170 148 151 164 162 133 125 111
Operating Profit % 17.00% 16.00% 14.00% 17.00% 17.00% 20.00% 20.00% 18.00% 18.00% 19.00% 21.00% 22.00% 19.00% 16.00% 15.00%
Depreciation 46 44 42 40 23 22 21 20 19 20 19 18 20 20 20
Interest 7 6 7 5 4 4 3 3 4 12 12 12 12 13 12

Profit and Earnings

Profit Before Tax 147 153 105 135 133 152 149 146 124 120 134 132 101 93 79
Tax 35 37 25 32 31 36 32 37 32 32 39 34 26 24 30
Net Profit 112 116 80 103 102 116 118 110 92 88 95 99 75 68 49
EPS 4.67 4.84 3.32 4.29 4.26 4.86 4.91 4.59 3.84 3.79 4.27 4.45 3.38 3.09 2.20

Indegene Cash Flow Screener - Liquidity Fundamentals

Screen INDGN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹651, and net cash flow was an inflow of ₹60.

Over the same period, investing activities used ₹508 and financing activities used ₹83.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Cash from Operations and Investing

Operating Activities 651 442 508 130 297 172 22 65
Investing Activities -508 -677 -327 -896 -158 -81 -16 -18

Financing and Net Cash

Financing Activities -83 288 -66 333 234 -132 136 -21
Net Cash Flow 60 52 115 -433 373 -41 143 25

Indegene Shareholding Pattern Screener

See Indegene shareholding pattern with promoter, FII, and DII holdings. Check Indegene promoter holding and ownership changes for INDGN on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 0.00%, foreign institutions 12.40%, domestic institutions 15.82% and the public 11.61%, spread across 132,280 shareholders.

The shareholder count was 132,280 in 2026-Sept, compared with 138,533 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Institutional Investors

FII Holding 12.40% 9.91% 10.27% 11.48% 11.30% 10.05% 5.24% 5.03%
DII Holding 15.82% 8.74% 8.30% 8.07% 6.96% 7.20% 4.96% 3.98%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 11.61% 12.49% 12.57% 12.45% 13.28% 13.51% 11.34% 26.41%
Other Holding 60.16% 68.86% 68.87% 68.00% 68.46% 69.24% 78.45% 64.58%
Shareholder Count 132,280 138,533 142,119 147,182 151,809 151,997 144,708 153,789

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Indegene. Indegene dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹2.25 per unit for 2026-March, a yield of 0.34%, compared with ₹2.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹2.25, ₹2.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹2.25 0.34%
2025-March ₹2.00 0.46%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Indegene Stock Index Membership - Nifty & Sensex

See which indices include Indegene stock. Check INDGN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 11 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSEIPO, BSE INDEX SMLCAP.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSEIPO
BSE INDEX SMLCAP
NIFTY 500
NIFTY IPO
NIFTY MIDSML 400
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 MULTICAP

Indegene Market Events Screener - Corporate Actions

Get Indegene corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Indegene stock events that may affect INDGN share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 29, 2026, with a record date of October 29, 2026.

It is followed by Annual General Meeting dated August 13, 2026 and Dividend dated July 31, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-29 2026-10-29 Quarterly Result Announcement NA -0.93%
2026-08-13 2026-08-13 Annual General Meeting NA 11.47%
2026-07-31 2026-07-31 Dividend ₹ 2.25 /share 2.95%
2026-07-30 2026-07-30 Quarterly Result Announcement NA 5.58%
2026-04-29 2026-04-29 Quarterly Result Announcement NA 3.54%
2026-01-29 2026-01-29 Quarterly Result Announcement NA -1.13%
2025-10-30 2025-10-30 Quarterly Result Announcement NA -1.67%
2025-07-31 2025-07-31 Quarterly Result Announcement NA -2.22%
2025-06-26 2025-06-26 Annual General Meeting NA -4.70%
2025-06-13 2025-06-13 Dividend ₹ 2.00 /share 5.49%
2025-04-28 2025-04-28 Quarterly Result Announcement NA -0.50%
2025-01-30 2025-01-30 Quarterly Result Announcement NA -6.18%
2024-10-28 2024-10-28 Quarterly Result Announcement NA 3.40%
2024-09-06 2024-09-06 Annual General Meeting NA 9.73%
2022-11-17 2022-11-17 Change Of Name NA -

Indegene Competitors Screener - Peer Stocks Comparison

Screen INDGN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 125,272 53.90 25,420 15.58% 2,003 61.89
Max Healthcare Institute 100,339 71.20 8,536 18.82% 1,442 76.17
Manipal Health Enterprises 92,333 104.20 10,521 25.80% 917 60.80
Aster DM Quality Care 64,325 116.10 4,769 11.25% 427 57.55
Fortis Healthcare 60,910 57.00 9,179 16.93% 1,064 57.30
Narayana Hrudayalaya 38,984 45.00 7,996 43.43% 811 61.49
Global Health 38,830 62.80 4,509 19.56% 554 64.64
Dr. Lal Path Labs 33,237 57.20 2,864 12.11% 510 54.28
Krishna Institute of Medical Sciences 32,269 163.00 3,931 28.16% 242 66.73
Syngene International 17,533 95.70 3,809 2.56% 317 61.78

Indegene Company Announcements - News & Reports Screener

Screen INDGN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 6, 2026.

The next most recent announcements are dated November 3, 2026 and October 31, 2026.

Date Update Actions
2026-11-06 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-03 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-10-31 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-30 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-10-30 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-29 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-10-29 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-29 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer -
2026-10-29 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-10-29 Unaudited Financial Results For The 2Nd Quarter And Half Year Ended 30Th September 2026 -
2026-10-29 Board Meeting Outcome for The Meeting Of The Board Of Directors Held On 29 October 2026 -
2026-10-26 Announcement under Regulation 30 (LODR)-Acquisition -
2026-10-22 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-15 Announcement under Regulation 30 (LODR)-Resignation of Director -
2026-10-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-08 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-10-06 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-09-30 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-30 Board Meeting Intimation for Consideration Of The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2026 Along With The Limited Review Report Of The Auditors Thereon. -
2026-09-28 Closure of Trading Window -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹654.95, within a 52-week range of ₹423.50 to ₹666.20. The P/E ratio is 38.80 and the P/B ratio is 4.75, with earnings per unit of ₹16.72. Market capitalisation stands at ₹15,632.72 Cr and the dividend yield is 0.34%. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.